Literature DB >> 3495584

Subcellular localization of human monocyte interleukin 1: evidence for an inactive precursor molecule and a possible mechanism for IL 1 release.

O Bakouche, D C Brown, L B Lachman.   

Abstract

IL 1 activity, as assayed by the proliferation of responsive mouse thymocytes and a human astrocytoma cell line, was detected on the membrane of 1% paraformaldehyde-fixed activated human monocytes. Resting, unactivated monocytes did not display IL 1 activity. Maximum induction of membrane IL 1 was obtained from monocytes treated with polyclonal activators, such as LPS or Staphylococcus aureus, whereas adherence was a weak inducer of membrane IL 1. Isolated cell compartments as plasma membranes, crude lysosomes, and crude cytosol from activated human monocytes expressed significant IL 1 activity, whereas the endoplasmic reticulum showed no IL 1 activity. Exposure to trypsin of either fixed, activated human monocytes or cell compartments from unfixed monocytes, revealed biologically active IL 1 in the membrane, crude lysosome, and crude cytosol, but not in the endoplasmic reticulum. The IL 1 activity in the purified cytosol, prepared by extraction with digitonin, was considerably increased by the trypsin treatment, whereas the increase in IL 1 activity within crude lysosomes and plasma membranes was less. The cell compartments from nonactivated monocytes did not express active IL 1 and trypsin treatment revealed no active IL 1, suggesting the absence of a pool of the trypsin-sensitive form of IL 1. The data confirm the presence of membrane-bound IL 1 in activated human monocytes and indicate that an inactive precursor molecule can be found in the cytosol of such cells. Furthermore, the absence of IL 1 activity either in its active form or as the inactive precursor in the endoplasmic reticulum suggests that IL 1 is not a conventionally secreted protein. Because IL 1 was found in the cytosol as a precursor and in the lysosomal fractions in an active form, these data suggest that after the synthesis and processing of the cytosolic precursor, the 17-kda IL 1, is released via lysosomal vesicles.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3495584

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  26 in total

Review 1.  IL-1beta: an endosomal exit.

Authors:  Mark D Wewers
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

Review 2.  Interleukin 1α and the inflammatory process.

Authors:  Nelson C Di Paolo; Dmitry M Shayakhmetov
Journal:  Nat Immunol       Date:  2016-07-19       Impact factor: 25.606

3.  The N-terminal propiece of interleukin 1 alpha is a transforming nuclear oncoprotein.

Authors:  F T Stevenson; J Turck; R M Locksley; D H Lovett
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

4.  Synthesis and apparent secretion of prothymosin alpha by different subpopulations of calf and rat thymocytes.

Authors:  F J Franco; C Diaz; M Barcia; P Arias; J Gomez-Marquez; F Soriano; E Mendez; M Freire
Journal:  Immunology       Date:  1989-06       Impact factor: 7.397

5.  Fibroblast interleukin 1 beta: synergistic stimulation by recombinant interleukin 1 and tumor necrosis factor and posttranscriptional regulation.

Authors:  J A Elias; M M Reynolds; R M Kotloff; J A Kern
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

6.  Regulation of insulin-like growth factor I gene expression in the human macrophage-like cell line U937.

Authors:  I Nagaoka; B C Trapnell; R G Crystal
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

7.  Acylation of monocyte and glomerular mesangial cell proteins. Myristyl acylation of the interleukin 1 precursors.

Authors:  S L Bursten; R M Locksley; J L Ryan; D H Lovett
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

Review 8.  Interleukin-1 and the effects of cyclooxygenase inhibitors on its biological activities.

Authors:  C A Dinarello
Journal:  Bull N Y Acad Med       Date:  1989-01

9.  Induction and suppression of cytokine release (tumour necrosis factor-alpha; interleukin-6, interleukin-1 beta) by Escherichia coli pathogenicity factors (adhesions, alpha-haemolysin).

Authors:  B König; W König
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

10.  Stimulation of monokine production by lipoteichoic acids.

Authors:  S Bhakdi; T Klonisch; P Nuber; W Fischer
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.